CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
ascorbic acid, vitamin E, beta carotene, selenium, zincbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00272428
NCT00272428Phase 3Completed

The SU.VI.MAX Study. A Randomized, Placebo-controlled Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Institut National de la Santé Et de la Recherche Médicale, France·interventional·Posted Jan 6, 2006·Updated Dec 17, 2009

In Brief

A Phase 3 clinical trial evaluating ascorbic acid, vitamin E, beta carotene, selenium, zinc for Healthy. Completed, across 1 site.

Detailed Summary

It has been suggested that a low dietary intake of antioxidant vitamins and minerals increases the incidence rate of cardiovascular disease and cancer. To date, however, the published results of randomized, placebo-controlled trials of supplements containing antioxidant nutrients have not provided clear evidence of a beneficial effect. We tested the efficacy of nutritional doses of supplementation with a combination of antioxidant vitamins and minerals in reducing the incidence of cancer and ischemic cardiovascular disease in the general population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesFrance

Timeline

Phase 3CompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 6, 2006
Enrollment StartOct 1, 1994
Study CompletionSep 1, 2005
TodayJul 2, 2026
Posted 20.5 years ago

Interventions

ascorbic acid, vitamin E, beta carotene, selenium, zincbehavioral